A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and saf...

Full description

Bibliographic Details
Main Authors: Sabeena Ahmed, Mohammad Mahbubul Karim, Allen G. Ross, Mohammad Sharif Hossain, John D. Clemens, Mariya Kibtiya Sumiya, Ching Swe Phru, Mustafizur Rahman, Khalequ Zaman, Jyoti Somani, Rubina Yasmin, Mohammad Abul Hasnat, Ahmedul Kabir, Asma Binte Aziz, Wasif Ali Khan
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:International Journal of Infectious Diseases
Subjects:
Ivermectin
Doxycycline
COVID-19
SARS-CoV-2
Bangladesh
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220325066

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220325066

Similar Items